Literature DB >> 1592293

Endometrioid carcinoma of the ovary presenting with an enlarged inguinal lymph node without evidence of abdominal carcinomatosis.

K F McGonigle1, M R Dudzinski.   

Abstract

It is generally recognized that ovarian cancer tends to remain intraabdominal even in advanced cases and that dissemination is usually by invasion of adjacent viscera, diffuse intraperitoneal implantation, and metastatic involvement of aortic and pelvic lymph nodes. Primary ovarian lymphatic drainage occurs via the infundibulopelvic ligament to the paraaortic nodes. The presence of an ovarian tumor extending into adjacent pelvic viscera may allow direct lymphatic continuity with inguinal, external, and common iliac lymph nodes. In the absence of such extension it is traditionally believed that the drainage via the infundibulopelvics is so important that only with its blockage, presumably by tumor emboli, can retrograde drainage to pelvic and inguinal nodes occur. We report a case of a patient presenting with a large metastatic inguinal lymph node from a primary epithelial ovarian cancer without evidence of disseminated intraabdominal disease or gross evidence of pelvic or paraaortic lymph node involvement.

Entities:  

Mesh:

Year:  1992        PMID: 1592293     DOI: 10.1016/0090-8258(92)90291-p

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Extra-abdominal Lymph Node Metastases as the First Presentation in Ovarian and Fallopian Tube Carcinomas.

Authors:  Maria Lúcia Moleiro; Alfredo Barroco Gouveia
Journal:  Reprod Sci       Date:  2022-08-08       Impact factor: 2.924

Review 2.  Primary Fallopian Tube Carcinoma Presenting with a Massive Inguinal Tumor: A Case Report and Literature Review.

Authors:  Michihide Maeda; Tsuyoshi Hisa; Shinya Matsuzaki; Shuichi Ohe; Shigenori Nagata; Misooja Lee; Seiji Mabuchi; Shoji Kamiura
Journal:  Medicina (Kaunas)       Date:  2022-04-23       Impact factor: 2.948

Review 3.  Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature.

Authors:  Xiao-Jun Yang; Fei-Yun Zheng; Yun-Sheng Xu; Rong-Ying Ou
Journal:  J Ovarian Res       Date:  2014-02-10       Impact factor: 4.234

4.  A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer.

Authors:  Ofer Lavie; David Edelman; Tally Levy; Ami Fishman; Ayala Hubert; Yakir Segev; Eli Raveh; Michal Gilon; Avraham Hochberg
Journal:  Arch Gynecol Obstet       Date:  2017-02-03       Impact factor: 2.344

5.  Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Czerniak; Tally Levy; Smadar Amiur; Jennifer Gallula; Imad Matouk; Rasha Abu-lail; Vladimir Sorin; Tatiana Birman; Nathan de Groot; Abraham Hochberg; Patricia Ohana
Journal:  J Transl Med       Date:  2009-08-06       Impact factor: 5.531

6.  Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrence.

Authors:  Aibek E Mirrakhimov; Nwabundo Nwankwo; Aram Barbaryan; Raya Saba; Alaa M Ali; Shawn G Kwatra; Nasir Hussain; Mourad H Senussi; Erwin Velasquez Kho; Alan D Gilman
Journal:  Case Rep Oncol       Date:  2013-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.